2. What do providers have to do to meet cancer reporting objectives?
3. How long do providers have to respond to NJSCR’s requests during the onboarding process?
6. When will the NJSCR be prepared to begin testing MU2 data transmissions?
7. What can Providers do until onboarding begins?
8. What method of transmission does NJSCR support?
9. How often will NJSCR accept electronic transmissions?
12. Will NJSCR require Providers to “register intent” for their chosen reporting period?
13. What can Providers expect after registration is complete?
14. What are some of the tools available to Providers as part of MU2 activities?
15. Who can I contact for more information?
16. How can I stay abreast of MU updates from the NJSCR?
________________________________________
1. Who is required to report cancer information to the New Jersey State Cancer Registry (NJSCR) as part of Meaningful Use (MU)?
Cancer reporting by ambulatory care facilities and physicians (also referred to as Eligible Professionals (EP) or Providers) as part of MU is voluntary. However, New Jersey regulations require the reporting of all newly diagnosed cancer cases by hospitals, physicians, ambulatory care facilities, radiation treatment facilities and private laboratories; and, submitting data electronically is strongly encouraged (refer to Cancer Registry Regulation).
2. What do providers have to do to meet MU cancer reporting objectives?
- Providers can meet MU cancer reporting objectives by first registering their intent to submit cancer data for MU (Meaningful Use Registration for the New Jersey State Cancer Registry) AND doing ONE of the following:
- Achieving ongoing submission of data during your EHR reporting period, or
- Being engaged with the NJSCR in testing and validation of data, or
- Waiting for an invitation from the NJSCR to begin testing and validation.
3. How long do providers have to respond to NJSCR’s requests during the onboarding process?
Providers have 30 days to respond to NJSCR requests. Failure to respond within 30 days on two (2) separate occasions will not meet the cancer reporting objective.
4. Is the NJSCR able to certify that a Provider achieved Cancer Meaningful Use or met the public health objective for cancer reporting?
Meaningful Use is a mandate of the Centers for Medicare and Medicaid Services (CMS); therefore NJSCR is not a designated certifying authority. NJSCR can only acknowledge that a Provider submitted ongoing cancer information to the NJSCR during the Provider’s EHR reporting period.
5. Is the NJSCR prepared to accept electronically transmitted cancer case information from Providers in the Clinical Document Architecture(CDA) format, as required by MU?
The NJSCR is currently accepting electronically transmitted cancer cases information. Providers are encouraged to begin the submission process by registering their intent with the NJSCR - Meaningful Use Registration for the New Jersey State Cancer Registry.
6. Is the NJSCR prepared to begin testing MU data transmissions?
The NJSCR is currently testing data for MU data transmissions. NJSCR currently uses MoveIT to receive MU (Promoting Interoperability) files. After you have completed registration, please email NJSCR.MU2@doh.nj.gov to set up an account.
7. What can Providers do until onboarding begins?
Providers may prepare to validate their MU transmission data by using the validation tool developed by the National Institute of Standards and Technology (NIST). The validation tool contains rules for Implementation Guide for Ambulatory Healthcare Provider Reporting to Central Cancer Registries (and all associated and referenced specifications) as referenced in Meaningful Use guidelines. More information about the validation tool can be found at Meaningful Use Cancer Registry Report Validation.
8. What method of transmission does NJSCR support?
NJSCR currently uses MoveIT to receive MU (Promoting Interoperability) files. After you have completed registration, please email NJSCR.MU2@doh.nj.gov to set up an account.
9. How often will NJSCR accept electronic transmissions?
Although Providers are required to report all newly diagnosed cancer cases within 6 months of diagnosis as part of the cancer reporting statute, the NJSCR may accept transmissions more frequently during the onboarding process to facilitate successful ongoing MU submission of cancer case information for the Provider’s entire EHR reporting period. After the initial onboarding process EHR reporting period for eligible professionals begins and ends based on the calendar year. EHR reporting period for all providers is any continuous 90-day period within calendar year. Eligible professionals may select an EHR reporting period for any continuous 90 days during the calendar year.
10. Would an EHR vendor be able to obtain one set of credentials to connect, or is each provider organization required to have a distinct login?
Each EHR vendor will have one set of credentials to connect and transfer data files for all the providers they service. However, the NJSCR will require that Providers be identified within each transmission in order to document the source of the record (e.g. the individual providers and/or the group practice). This information will also be important for ongoing monitoring and quality assurance.
11. Does NJSCR accept data in the format set forth by the Implementation Guide for Healthcare Providers Reporting to Central Cancer Registries?
Yes. NJSCR encourages Providers to submit MU data in the format described in the Implementation Guide for Ambulatory Healthcare Provider Reporting to Central Cancer Registries. If your EHR is not a certified electronic health record technology (CEHRT) but you would like to submit electronic cancer data to NJSCR, please visit Cancer Reporting for physicians, ambulatory care centers, radiation treatment facilities as other formats and data transmission options are available to providers to help meet their state reporting obligations.
12. Will NJSCR require Providers to “register intent” for their chosen reporting period?
Yes. Providers must register their intent to submit MU data before the onboarding process can begin. The information provided through the registration process will help to facilitate the onboarding process. To register your intent, go to Meaningful Use Registration for the New Jersey State Cancer Registry. After registration, Providers will receive an email acknowledging registration. The email should be retained as documentation that you have successfully registered your intent.
13. What can Providers expect after registration is complete?
The NJSCR will contact registered Providers to begin the onboarding process, which will include sending data for testing and correcting data that fails NJSCR validity protocols. The onboarding process will be an iterative process and may require several test cycles before the data can be validated. The onboarding process will end when data that have passed the validation process are submitted on an ongoing basis during the Provider’s EHR reporting period.
14. What are some of the tools available to Providers as part of MU activities?
One tool that can be useful to Providers as they prepare to submit MU data to NJSCR is the validation tool developed by the National Institute of Standards and Technology (NIST). The validation tool contains rules for IG for Ambulatory Healthcare Provider Reporting to Central Cancer Registries (and all associated and referenced specifications) as referenced in MU guidelines. More information about Meaningful Use Cancer Registry Report Validation.
15. Who can I contact for more information?
If you would like more information or have other questions, please email the NJSCR MU coordinator(s) at NJSCR.MU2@doh.nj.gov. Please be sure to include your full name and contact information.
16. How can I stay abreast of MU updates from the NJSCR?
You can stay abreast of NJSCR MU activities by visiting our MU website periodically and/or subscribing to our mailing list. You can subscribe to our mailing list during the registration process. All correspondence with regard to NJSCR MU activities will be sent from rbhs_njscr_mu2providers-request@email.rutgers.edu.
